The aim of this study is to find a suitable substitution for diglycidyl ether bisphenol A (DGEBA) to avoid the devastating side effects of bisphenol A.
No takes yet. Share an insight, caveat, or question.
Nikafshar et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: